Enrolling by invitationPhase 1NCT07398872
Safety and Efficacy of AAV9. hMCOLN1co For Patients With Mucolipidosis Type IV
Studying Mucolipidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Intervention
- AAV9.hMCOLN1co(biological)
- Enrollment
- 1 enrolled
- Eligibility
- 8 years · All sexes
- Timeline
- 2026 – 2031
Study locations (1)
- Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07398872 on ClinicalTrials.gov